Elekta AB (publ) (EKTAY) to Release Quarterly Earnings on Thursday

Elekta AB (publ) (OTCMKTS:EKTAY) is expected to be posting its quarterly earnings results on Thursday, March 6th. Analysts expect Elekta AB (publ) to post earnings of $0.09 per share and revenue of $444.70 million for the quarter.

Elekta AB (publ) (OTCMKTS:EKTAY) last announced its quarterly earnings results on Friday, February 21st. The company reported $0.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.01). The business had revenue of $416.86 million for the quarter, compared to analyst estimates of $435.89 million. Elekta AB (publ) had a return on equity of 11.07% and a net margin of 5.65%. On average, analysts expect Elekta AB (publ) to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Elekta AB (publ) Stock Performance

Shares of EKTAY opened at $5.64 on Thursday. Elekta AB has a 12-month low of $5.25 and a 12-month high of $8.24. The firm’s 50 day moving average is $5.72 and its 200-day moving average is $6.08. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.05 and a quick ratio of 0.81. The stock has a market capitalization of $2.16 billion, a P/E ratio of 22.56 and a beta of 1.22.

Elekta AB (publ) Cuts Dividend

The business also recently announced a dividend, which will be paid on Thursday, March 27th. Shareholders of record on Friday, March 7th will be given a $0.1072 dividend. The ex-dividend date of this dividend is Friday, March 7th. Elekta AB (publ)’s payout ratio is 40.00%.

Analysts Set New Price Targets

Separately, Sanford C. Bernstein raised shares of Elekta AB (publ) from a “strong sell” rating to a “hold” rating in a research report on Wednesday, January 29th.

Elekta AB (publ) Company Profile

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.